Portfolio company
BCI Pharma
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotech company develops selective kinase inhibitors and chemical libraries for pharmaceutical partners to treat cancer, inflammation and women's health conditions.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Confluence Life Sciences
This biopharmaceutical company develops kinase inhibitors to treat inflammatory disorders and cancer for pharmaceutical and biotechnology industries.
Spark BioPharma
The company develops small-molecule therapeutics using a phenotypic discovery platform for pharmaceutical partners treating cancer, inflammation and immune disorders.
Pharmacyclics
This company develops small-molecule medicines for patients with cancer and immune-mediated diseases.
1200 Pharma
This biotechnology firm develops small molecule therapies and drug intellectual property for the treatment of cancer patients.
Brickell Bio
This pharmaceutical company develops prescription therapeutics for patients with autoimmune, inflammatory and debilitating skin diseases.
BlossomHill Therapeutics
This biopharmaceutical company develops small molecule medicines to treat patients with various forms of cancer and autoimmune disorders.
Kanvas Biosciences
This company develops microbiome mapping platforms and live biotherapeutic products for pharmaceutical companies and research institutions focused on treating cancer and inflammatory diseases.
Biotheryx
The company develops protein degrader medicines for patients with cancer and inflammatory diseases.